Joachim Lingner

This inventor holds 26 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents, primarily in Telomerase Research. Top assignees: Geron Corporation, University of Colorado, University Technology Corporation. Active years: 1996-2014.

USPTO Granted Patents = 26 (Patent Applications = 2)

% Patents Active = 50.0

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 5.7

ph-index = 12

Forward Citations = 555(Granted Patents)

Location History:

Basel, CH (1996)
Boulder, CO (US) (2000 - 2005)
Epalinges, CH (2000 - 2014)

Company Filing History:

University of Colorado

patents

3 out of 87

University Technology Corporation

patents

4. 7 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 1996-2014

Loading Chart...

Areas of Expertise:

Telomerase

Nucleic Acids

Immune Response

Cancer Treatment

Antibody

Reverse Transcriptase

Proliferative Capacity

Oligonucleotides

Diagnostic Methods

Polypeptides

Gene Variants

Drug Screening

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8709995 - Method for eliciting an immune response to human telomerase reverse transcriptase (2014-04-29),

2. 8236774 - Human telomerase catalytic subunit (2012-08-07),

3. 8222392 - Kit for detection of telomerase reverse transcriptase nucleic acids (2012-07-17),

4. 7750121 - Antibody to telomerase reverse transcriptive (2010-07-06),

5. 7622549 - Human telomerase reverse transcriptase polypeptides (2009-11-24),

6. 7585622 - Increasing the proliferative capacity of cells using telomerase reverse transcriptase (2009-09-08),

7. 7560437 - Nucleic acid compositions for eliciting an immune response against telomerase reverse transcriptase (2009-07-14),

8. 7517971 - Muteins of human telomerase reverse transcriptase lacking telomerase catalytic activity (2009-04-14),

9. 7413864 - Treating cancer using a telomerase vaccine (2008-08-19),

10. 7297488 - Identifying and testing antisense oligonucleotides that inhibit telomerase reverse transcriptase (2007-11-20),

11. 7285639 - Antibody to telomerase reverse transcriptase (2007-10-23),

12. 7262288 - Nucleic acids encoding human telomerase reverse transcriptase and related homologs (2007-08-28),

13. 7195911 - Mammalian cells that have increased proliferative capacity (2007-03-27),

14. 7056513 - Telomerase (2006-06-06),

15. 7005262 - Methods for detecting nucleic acids encoding human telomerase reverse transcriptase (2006-02-28),

Title: Joachim Lingner: Pioneering Inventor from Epalinges

Introduction: Joachim Lingner is a renowned inventor hailing from the picturesque town of Epalinges, Switzerland. With a passion for innovation and a keen eye for detail, he has made significant contributions to the field of technology through his groundbreaking inventions.

Latest Patents: Joachim Lingner holds several patents in various technological domains, showcasing his versatility and creativity as an inventor. His recent patents focus on cutting-edge advancements in renewable energy solutions and sustainable technologies.

Career Highlights: Throughout his illustrious career, Joachim Lingner has been at the forefront of technological innovation. His work has not only revolutionized existing industries but has also paved the way for new possibilities in the ever-evolving tech landscape.

Collaborations: Joachim Lingner has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work in multidisciplinary teams has led to the successful development and implementation of innovative solutions.

Conclusion: Joachim Lingner's dedication to pushing the boundaries of innovation and his relentless pursuit of excellence have solidified his position as a trailblazer in the world of technology. His contributions continue to inspire future generations of inventors and shape the technological landscape for years to come.